Soterios Pharma Wraps Up Phase II Enrollment for STS-01 in Alopecia Areata

Soterios Pharma Wraps Up Phase II Enrollment for STS-01 in Alopecia Areata

Soterios Pharma, a clinical-stage pharmaceutical company, has announced the completion of target enrollment for its Phase II trial with STS-01,…

Read More »